Silverback Therapeutics Inc
NASDAQ:SBTX
Income Statement
Earnings Waterfall
Silverback Therapeutics Inc
Revenue
|
1.3m
USD
|
Operating Expenses
|
-36.8m
USD
|
Operating Income
|
-35.5m
USD
|
Other Expenses
|
834k
USD
|
Net Income
|
-34.7m
USD
|
Income Statement
Silverback Therapeutics Inc
Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|
Revenue | ||||
Revenue |
0
N/A
|
0
N/A
|
1
N/A
|
|
Operating Income | ||||
Operating Expenses |
(33)
|
(90)
|
(37)
|
|
Selling, General & Administrative |
(8)
|
(28)
|
(18)
|
|
Research & Development |
(25)
|
(62)
|
(18)
|
|
Operating Income |
(33)
N/A
|
(90)
-172%
|
(36)
+60%
|
|
Pre-Tax Income | ||||
Interest Income Expense |
(0)
|
0
|
(1)
|
|
Total Other Income |
0
|
0
|
2
|
|
Pre-Tax Income |
(33)
N/A
|
(89)
-172%
|
(35)
+61%
|
|
Net Income | ||||
Income from Continuing Operations |
(33)
|
(89)
|
(35)
|
|
Net Income (Common) |
(33)
N/A
|
(89)
-172%
|
(35)
+61%
|
|
EPS (Diluted) |
-0.95
N/A
|
-2.56
-169%
|
-0.87
+66%
|